Pharmacogenomics of systemic antifungal agents
Publication
, Journal Article
Johnson, MD
Published in: Current Fungal Infection Reports
June 1, 2009
The genomic era offers a multitude of new technologies that may make the promise of personalized medicine a reality for patients in this century. Numerous new antifungal agents have been developed over the past two decades, but use of these agents requires optimization of pharmacokinetics and dosing to achieve efficacy and minimize toxicity. This article reviews the potential application of pharmacogenomics to the use of antifungal agents, highlighting genetic variation that may affect absorption, distribution, metabolism, and elimination of these compounds. © 2009 Current Medicine Group, LLC.
Duke Scholars
Published In
Current Fungal Infection Reports
DOI
EISSN
1936-377X
ISSN
1936-3761
Publication Date
June 1, 2009
Volume
3
Issue
2
Start / End Page
111 / 116
Related Subject Headings
- 3207 Medical microbiology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Johnson, M. D. (2009). Pharmacogenomics of systemic antifungal agents. Current Fungal Infection Reports, 3(2), 111–116. https://doi.org/10.1007/s12281-009-0015-9
Johnson, M. D. “Pharmacogenomics of systemic antifungal agents.” Current Fungal Infection Reports 3, no. 2 (June 1, 2009): 111–16. https://doi.org/10.1007/s12281-009-0015-9.
Johnson MD. Pharmacogenomics of systemic antifungal agents. Current Fungal Infection Reports. 2009 Jun 1;3(2):111–6.
Johnson, M. D. “Pharmacogenomics of systemic antifungal agents.” Current Fungal Infection Reports, vol. 3, no. 2, June 2009, pp. 111–16. Scopus, doi:10.1007/s12281-009-0015-9.
Johnson MD. Pharmacogenomics of systemic antifungal agents. Current Fungal Infection Reports. 2009 Jun 1;3(2):111–116.
Published In
Current Fungal Infection Reports
DOI
EISSN
1936-377X
ISSN
1936-3761
Publication Date
June 1, 2009
Volume
3
Issue
2
Start / End Page
111 / 116
Related Subject Headings
- 3207 Medical microbiology
- 3202 Clinical sciences